Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Both are effective for PCOS
Another study assessing the addition of GLP-1 analogues (liraglutide or exenatide) to existing insulin therapy in type 2 diabetes patients showed reductions in HbA1c, body weight and insulin dosage
Food and Drug Administration on Friday announced the approval of pharmaceutical giant Novo Nordisk's Wegovy (semaglutide) injection for adults who either have obesity or are overweight and have at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol
I am a firm believer that doses of GLP-1s can and should be minimized and individualized
The key is rotating between sites and not injecting into the same spot repeatedly
